Alicyclobacillus acidocaldarius Squalene Hopene Cyclase was evolved to a biocatalyst suitable for (À)-Ambrox production at industrial scale. One round of random mutagenesis led to the identification of three variants with (E,E)-homofarnesol conversion properties improved about 1.5-to 10-fold over that of the wild type enzyme. Eight distinct amino acid mutations were identified overall; only one mutation was at the active site of the enzyme. Each of the three variants contained only two or three mutations over the 631 amino acids of the Alicyclobacillus acidocaldarius Squalene Hopene Cyclase polypeptide chain. Mutations responsible for improved (E,E)-homofarnesol conversion were identified. Investigations on reaction conditions led to the selection of one variant, with which reaction parameters were optimized towards process-relevant conditions. A whole cell biotransformation process is presented in which Escherichia coli cells producing an improved Squalene Hopene Cyclase variant allows the conversion of 125 g/L (E,E)homofarnesol in 72 hours. The developed process for the production of the fragrance ingredient (À)-Ambrox as Ambrofix expands the biocatalysis toolbox by setting out a general basis for biocatalytic Squalene Hopene Cyclase cyclization reactions at industrial scale.

No abstract

The synthesis of an europium tris-bipyridine cryptate labeled 2'-deoxyuridine-5 '-triphosphate analog (K-11-dUTP) is described. This labeled triphosphate was incorporated into DNA through enzymatic reactions with terminal transferase and DNA polymerases. The enzymatic reactions were monitored by TRACE (Time Resolved Amplification of Cryptate Emission), a homogeneous method using Fluorescence Resonance Energy Transfer (FRET) from an europium cryptate as donor to a modified allophycocyanine as acceptor.

No abstract

Screening of prokaryotic genomes in order to identify enzymes with a desired catalytic activity can be performed in vivo in bacterial cells. We propose a strategy of in vitro expression screening of large prokaryotic genomic libraries based on Escherichia coli cell-free transcription-translation systems. Because cell-based expression may be limited by poor yield or protein misfolding, cell-free expression systems may be advantageous in permitting a more comprehensive screen under conditions optimized for the desired enzyme activity. However, monocistronic messages with an improved leader initiation context are typically used for protein production in vitro. Here, we describe successful use of a Pseudoalteromonas genomic DNA library for in vitro expression of DNA fragments carrying multiple open reading frames (ORFs) in the context of their authentic translation initiation sites and regulatory regions. We show that ORFs located far from the 5' and 3' ends of polycistronic transcripts can be expressed at a sufficient level in an in vitro transcription-translation system in order to allow functional screening. We demonstrate the overall cell-free functional screen strategy with the successful selection of an esterase from Pseudoalteromonas.